Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.

The Journal of Dermatology
Thomas LugerZuotao Zhao

Abstract

Atopic dermatitis is a chronic relapsing, inflammatory skin disorder associated with skin barrier dysfunction, the prevalence of which has increased dramatically in developing countries. In this article, we propose a treatment algorithm for patients with mild-to-moderate and severe atopic dermatitis flares in daily clinical practice. An international panel of 15 dermatology and allergy experts from eight countries was formed to develop a practical algorithm for the treatment of patients with atopic dermatitis, with a particular focus on topical therapies. In cases of mild-to-moderate atopic dermatitis involving sensitive skin areas, the topical calcineurin inhibitor pimecrolimus should be applied twice daily at the first signs of atopic dermatitis. For other body locations, patients should apply a topical calcineurin inhibitor, either pimecrolimus or tacrolimus, twice daily at the first signs of atopic dermatitis, such as pruritus, or twice weekly in previously affected skin areas. Emollients should be used regularly. Patients experiencing acute atopic dermatitis flares in sensitive skin areas should apply a topical corticosteroid twice daily or alternate once-daily topical corticosteroid/topical calcineurin inhibitor until sym...Continue Reading

References

Jan 1, 1993·Dermatology : International Journal for Clinical and Investigative Dermatology
Sep 18, 1998·The Journal of Investigative Dermatology·S ReitamoA I Lauerma
May 16, 2000·The British Journal of Dermatology·C R CharmanH C Williams
Feb 15, 2001·The Journal of Allergy and Clinical Immunology·A Panhans-GrossT Bieber
Aug 10, 2002·The Journal of Allergy and Clinical Immunology·Alexander KappUNKNOWN Flare Reduction in Eczema with Elidel (infants) multicenter investigator study group
Oct 26, 2002·Dermatology : International Journal for Clinical and Investigative Dermatology·Michael MeurerUNKNOWN CASM-DE-01 study group
Nov 13, 2003·Archives of Disease in Childhood·B R AllenT J Stephenson
Nov 13, 2004·The Journal of Allergy and Clinical Immunology·Roland KaufmannUNKNOWN CASM981CDE04-Study Group
Feb 5, 2005·Journal of the American Academy of Dermatology·Kim A PappCarle Paul
Mar 22, 2005·Journal of Cutaneous Medicine and Surgery·Charles W Lynde
Jun 9, 2005·The Journal of Allergy and Clinical Immunology·Wolfram HoetzeneckerAdelheid Elbe-Bürger
Jul 16, 2005·Journal of the American Academy of Dermatology·M Shane ChapmanUNKNOWN US Tacrolimus Ointment Study Group
Sep 24, 2005·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Doris StaabUNKNOWN CASM981CDE04-Study Group
Oct 4, 2005·Journal of the American Academy of Dermatology·Zoe DraelosCarle F Paul
Dec 31, 2005·Journal of the American Academy of Dermatology·Ulrich R HenggeMichael J Cork
Jul 4, 2006·The Journal of Allergy and Clinical Immunology·Cezmi A AkdisUNKNOWN European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology
Dec 21, 2006·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J PendersP A van den Brandt
Dec 25, 2007·The Journal of Allergy and Clinical Immunology·Hywel WilliamsUNKNOWN International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups
Jan 24, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·J RingD Schneider
May 1, 2008·Allergy·A WollenbergUNKNOWN European Tacrolimus Ointment Study Group
Jun 6, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·H Markus WeissAndreas Billich
Sep 2, 2009·The Journal of Allergy and Clinical Immunology·Jens-Michael JensenEhrhardt Proksch
Sep 8, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·U DarsowUNKNOWN European Task Force on Atopic Dermatitis/EADV Eczema Task Force
Jun 16, 2011·The British Journal of Dermatology·H Aubert-WastiauxS Barbarot
Sep 20, 2011·International Journal of Dermatology·Johanna M MandelinNasrullah Undre
Dec 15, 2011·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Wade Watson, Sandeep Kapur
Feb 22, 2012·International Journal of Dermatology·Pavel V Chernyshov
Mar 1, 2012·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Andrei ShpakouJan Zejda
Jul 19, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·J RingUNKNOWN Global Allergy and Asthma European Network (GA2LEN)
Oct 25, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·U Blume-Peytavi, M Metz
Dec 21, 2012·Indian Journal of Dermatology, Venereology and Leprology·Pavel V ChernyshovJana Hercogova
May 13, 2014·Journal of the American Academy of Dermatology·Robert SidburyUNKNOWN American Academy of Dermatology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Magdalena Czarnecka-Operacz, Dorota Jenerowicz
© 2021 Meta ULC. All rights reserved